At today’s close, the company’s market capitalization was approximately $340 billion.
Latest Quarterly Results
For the fiscal second quarter ended Dec. 31, 2025, Procter & Gamble reported:
- Net sales: $22.2 billion, up 1% year over year.
- Organic sales: unchanged versus the prior year.
- Net earnings: $4.3 billion.
- Diluted EPS: $1.78, down 5% from the prior year.
- Core EPS: $1.88, flat year over year.
Segment Organic Sales Trends (YoY):
- Beauty: up ~4%
- Health Care: up ~3%
- Grooming: mixed/modest changes
- Fabric & Home Care: modest changes
- Baby, Feminine & Family Care: down ~4%
Financial Trends
Chart 1: Segment Performance
Chart 2: Market Performance
Year-to-Date Results
Through the first two quarters of fiscal year 2026, based on combined available quarterly disclosures:
- Net sales (YTD): approximately $44.6 billion.
- Net income (YTD): approximately $9.1 billion.
- Organic sales (YTD): flat versus the prior year period.
- Core EPS (YTD): reflects stability year over year.
The year-to-date data show continued modest top-line growth but persistent volume pressures in several core product categories.
Business & Operations Update
In quarterly commentary, Procter & Gamble said pricing actions helped offset volume declines in essential categories during the quarter. The company disclosed that gross margins narrowed, pressured by unfavorable product mix, reinvestments, and increased costs linked to tariffs and transportation. Productivity savings partially mitigated cost headwinds. P&G returned $4.8 billion to shareholders in the quarter through dividends and share repurchases.
Equity Analyst Commentary
Institutional research noted that Procter & Gamble’s revenue slightly missed consensus expectations, reflecting soft consumer demand in staples categories, while earnings measures modestly exceeded forecasts. Analysts highlighted volume declines and tariff-related cost pressures as factors influencing near-term results.
Guidance & Outlook
In its earnings release, Procter & Gamble reiterated its guidance ranges for full fiscal 2026: all-in sales growth of 1% to 5% and organic sales growth of flat to 4%, with core EPS growth expected in line with previously stated ranges. Investors are watching pricing trends, tariff cost impacts, and consumer spending patterns as context for the company’s performance in the second half of the fiscal year.
Performance Summary
Procter & Gamble shares declined after reporting second-quarter results showing 1% revenue growth and flat organic sales. Net earnings and core EPS were steady year over year. Year-to-date figures suggest continued modest top-line expansion and stable earnings. Segment results varied, with gains in beauty and health care offset by pressures in family care. The company maintained its fiscal guidance ranges.